SEC Filings | NeuroBo Pharmaceuticals, Inc.

Filing date	Form	Description	Filing Group	View
Nov 28, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0001140361-22-043315.rtf 0001140361-22-043315.xls 0001140361-22-043315.pdf View HTML
May 26, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0001140361-23-027028.rtf 0001140361-23-027028.xls 0001140361-23-027028.pdf View HTML
Sep 1, 2017	POS AM	Post-effective amendment to an S-Type filing	Registration Statements	0001104659-17-055232.rtf 0001104659-17-055232.xls 0001104659-17-055232.pdf View HTML
Oct 11, 2019	S-4/A	Pre-effective amendment to an S-4 filing	Registration Statements	0001047469-19-005694.rtf 0001047469-19-005694.xls 0001047469-19-005694.pdf View HTML
Oct 30, 2019	S-4/A	Pre-effective amendment to an S-4 filing	Registration Statements	0001047469-19-005955.rtf 0001047469-19-005955.xls 0001047469-19-005955.pdf View HTML
Nov 4, 2019	S-4/A	Pre-effective amendment to an S-4 filing	Registration Statements	0001047469-19-006051.rtf 0001047469-19-006051.xls 0001047469-19-006051.pdf View HTML
Mar 2, 2021	PRER14A	Proxy soliciting materials. Revised preliminary material	Proxy Filings	0001104659-21-030444.rtf 0001104659-21-030444.xls 0001104659-21-030444.pdf View HTML
Jun 10, 2021	PRER14A	Proxy soliciting materials. Revised preliminary material	Proxy Filings	0001104659-21-079414.rtf 0001104659-21-079414.xls 0001104659-21-079414.pdf View HTML
Sep 14, 2016	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001558370-16-008353.rtf 0001558370-16-008353.xls 0001558370-16-008353.pdf View HTML
Nov 2, 2016	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0001558370-16-009022.rtf 0001558370-16-009022.xls 0001558370-16-009022.pdf View HTML

Data provided by Kaleidoscope.